Display Settings:

Format

Send to:

Choose Destination

    FEMS Microbiol Lett. 1997 Jun 15;151(2):263-8.

    Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains.

    Löffler J, Kelly SL, Hebart H, Schumacher U, Lass-Flörl C, Einsele H.

    Medizinische Klinik, Abt. II, Universität Tübingen, Germany.

    The target enzyme for fluconazole is sterol 14 alpha-demethylase, a cytochrome P450 encoded by cyp51. One mechanism of fluconazole resistance likely to occur in Candida albicans is through an altered target site. To test this hypothesis DNA sequencing of the cyp51 coding sequence from 19 fluconazole-resistant and 19 fluconazole-sensitive C. albicans was undertaken. A number of point mutations were identified in the resistant isolates which were not present in the sensitive ones: F105L (five), E266D (five), K287R (one), G448G (one), G450E (one), G464S (three) and V488I (one). These alterations are discussed in the light of a molecular model of the enzyme regarding potential roles in resistance. It was also demonstrated that sequence-specific primers can be employed to identify polymorphisms which may be associated with resistance; diagnostic tests for resistant strains will prove of value in combating this serious clinical problem.

    PMID: 9228762 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Patient drug information

    • Fluconazole (Diflucan®)

      Fluconazole is used to treat fungal infections, including yeast infections of the vagina, mouth, throat, esophagus (tube leading from the mouth to the stomach), abdomen (area between the chest and waist), lungs, blood, a...